EA
Emerald Advisers’s United Therapeutics UTHR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $249K | Buy |
867
+15
| +2% | +$4.31K | 0.01% | 212 |
|
|
2025
Q1 | $263K | Sell |
852
-1,061
| -55% | -$327K | 0.01% | 195 |
|
|
2024
Q4 | $675K | Sell |
1,913
-19
| -1% | -$6.7K | 0.03% | 155 |
|
|
2024
Q3 | $692K | Buy |
+1,932
| New | +$692K | 0.03% | 155 |
|
|
2023
Q4 | – | Sell |
-1,376
| Closed | -$311K | – | 253 |
|
|
2023
Q3 | $311K | Sell |
1,376
-4,621
| -77% | -$1.04M | 0.02% | 189 |
|
|
2023
Q2 | $1.32M | Sell |
5,997
-72,089
| -92% | -$15.9M | 0.06% | 140 |
|
|
2023
Q1 | $17.5M | Sell |
78,086
-16,356
| -17% | -$3.66M | 0.84% | 49 |
|
|
2022
Q4 | $26.3M | Buy |
94,442
+1,189
| +1% | +$331K | 1.27% | 23 |
|
|
2022
Q3 | $19.5M | Sell |
93,253
-66,840
| -42% | -$14M | 1.01% | 35 |
|
|
2022
Q2 | $37.7M | Sell |
160,093
-43,266
| -21% | -$10.2M | 1.94% | 3 |
|
|
2022
Q1 | $36.5M | Buy |
203,359
+17,402
| +9% | +$3.12M | 1.39% | 18 |
|
|
2021
Q4 | $40.2M | Sell |
185,957
-3,850
| -2% | -$832K | 1.48% | 12 |
|
|
2021
Q3 | $35M | Buy |
189,807
+2,347
| +1% | +$433K | 1.27% | 21 |
|
|
2021
Q2 | $33.6M | Sell |
187,460
-7,068
| -4% | -$1.27M | 1.23% | 23 |
|
|
2021
Q1 | $32.5M | Sell |
194,528
-18,426
| -9% | -$3.08M | 1.17% | 20 |
|
|
2020
Q4 | $32.3M | Buy |
212,954
+19,992
| +10% | +$3.03M | 1.07% | 26 |
|
|
2020
Q3 | $19.5M | Sell |
192,962
-5,199
| -3% | -$525K | 0.8% | 52 |
|
|
2020
Q2 | $24M | Buy |
198,161
+68,104
| +52% | +$8.24M | 1.04% | 31 |
|
|
2020
Q1 | $12.3M | Buy |
+130,057
| New | +$12.3M | 0.71% | 53 |
|
|
2015
Q4 | – | Sell |
-6,749
| Closed | -$886K | – | 335 |
|
|
2015
Q3 | $886K | Sell |
6,749
-60
| -0.9% | -$7.88K | 0.05% | 262 |
|
|
2015
Q2 | $1.18M | Sell |
6,809
-6,240
| -48% | -$1.09M | 0.06% | 236 |
|
|
2015
Q1 | $2.13M | Sell |
13,049
-7,160
| -35% | -$1.17M | 0.11% | 210 |
|
|
2014
Q4 | $2.62M | Buy |
+20,209
| New | +$2.62M | 0.14% | 187 |
|